title: Myo-pericarditis secondary to ledipasvir-sofosbuvir therapy.
authors.affiliation: Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Allison
authors.initials: A
authors.lastname: Padegimas
authors.affiliation: Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Forde
authors.affiliation: Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Lee R
authors.initials: LR
authors.lastname: Goldberg
authors.affiliation: Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: edo.birati@uphs.upenn.edu.
authors.forename: Edo Y
authors.initials: EY
authors.lastname: Birati
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects; D001562:Benzimidazoles / Q000009:adverse effects*; D004452:Echocardiography; D004562:Electrocardiography; D005449:Fluorenes / Q000009:adverse effects*; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000139:chemically induced* / Q000175:diagnosis; D010493:Pericarditis / Q000139:chemically induced* / Q000175:diagnosis; D000069474:Sofosbuvir / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D005449:Fluorenes; C586541:ledipasvir; D000069474:Sofosbuvir
keywords: Cardiomyopathy; HCV; Myocarditis; Sofosbuvir-ledipasvir